GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » Cyclically Adjusted Book per Share

ImmunoPrecise Antibodies (STU:TQB) Cyclically Adjusted Book per Share : €1.04 (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ImmunoPrecise Antibodies's adjusted book value per share for the three months ended in Jan. 2025 was €0.369. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.04 for the trailing ten years ended in Jan. 2025.

During the past 12 months, ImmunoPrecise Antibodies's average Cyclically Adjusted Book Growth Rate was 15.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 53.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -4.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -25.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of ImmunoPrecise Antibodies was 53.40% per year. The lowest was -54.20% per year. And the median was -5.90% per year.

As of today (2025-05-25), ImmunoPrecise Antibodies's current stock price is €0.482. ImmunoPrecise Antibodies's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2025 was €1.04. ImmunoPrecise Antibodies's Cyclically Adjusted PB Ratio of today is 0.46.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ImmunoPrecise Antibodies was 85.00. The lowest was 0.31. And the median was 1.69.


ImmunoPrecise Antibodies Cyclically Adjusted Book per Share Historical Data

The historical data trend for ImmunoPrecise Antibodies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Cyclically Adjusted Book per Share Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.77 0.91

ImmunoPrecise Antibodies Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.91 0.94 0.93 1.04

Competitive Comparison of ImmunoPrecise Antibodies's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, ImmunoPrecise Antibodies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImmunoPrecise Antibodies's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's Cyclically Adjusted PB Ratio falls into.


;
;

ImmunoPrecise Antibodies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ImmunoPrecise Antibodies's adjusted Book Value per Share data for the three months ended in Jan. 2025 was:

Adj_Book= Book Value per Share /CPI of Jan. 2025 (Change)*Current CPI (Jan. 2025)
=0.369/134.0288*134.0288
=0.369

Current CPI (Jan. 2025) = 134.0288.

ImmunoPrecise Antibodies Quarterly Data

Book Value per Share CPI Adj_Book
201503 -0.285 99.621 -0.383
201506 -0.273 100.684 -0.363
201509 -0.269 100.392 -0.359
201512 -0.293 99.792 -0.394
201603 -0.289 100.470 -0.386
201606 -0.254 101.688 -0.335
201609 0.072 101.861 0.095
201701 0.362 102.456 0.474
201704 0.278 103.167 0.361
201707 0.218 103.278 0.283
201710 0.758 104.070 0.976
201801 0.702 104.578 0.900
201804 0.733 105.708 0.929
201807 0.707 106.324 0.891
201810 1.029 106.695 1.293
201901 0.973 106.200 1.228
201904 0.885 107.818 1.100
201907 0.786 108.250 0.973
201910 0.736 108.577 0.909
202001 0.731 108.841 0.900
202004 0.707 108.173 0.876
202007 0.867 109.318 1.063
202010 1.192 109.861 1.454
202101 1.130 110.364 1.372
202104 1.987 112.673 2.364
202107 1.946 115.183 2.264
202110 1.821 116.696 2.091
202201 1.716 118.619 1.939
202204 2.255 121.978 2.478
202207 2.027 125.002 2.173
202210 1.836 125.734 1.957
202301 1.694 126.223 1.799
202304 1.561 127.992 1.635
202307 1.471 128.974 1.529
202310 1.435 129.810 1.482
202401 1.295 130.124 1.334
202404 0.858 132.289 0.869
202407 0.809 132.708 0.817
202410 0.720 133.182 0.725
202501 0.369 134.029 0.369

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


ImmunoPrecise Antibodies  (STU:TQB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

ImmunoPrecise Antibodies's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.482/1.04
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ImmunoPrecise Antibodies was 85.00. The lowest was 0.31. And the median was 1.69.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ImmunoPrecise Antibodies Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

ImmunoPrecise Antibodies Headlines

No Headlines